Led · Seed · Jun 2026

Hypha provides an AI-native asset intelligence platform designed to unify fragmented investment data and workflows into structured, actionable insights across the asset lifecycle. The company has focused early efforts on complex, data-intensive sectors including private credit, private equity, professional services, healthcare, senior housing and multifamily real estate. Hypha has partnered with industry firms as design partners—such as MONTICELLOAM, LLC and 980Investments—to embed institutional underwriting and asset management knowledge into its intelligence layer. The team includes hires and advisors from the investment and technology sectors, including Chris Connolly as Head of Go-to-Market and Avi Mayer as a Strategic Advisor. Hypha raised $50 million in a Seed round to expand engineering, go-to-market, design and marketing teams, accelerate product development and grow its R&D presence in Tel Aviv. The company was co-founded in 2025 and is headquartered in New York City.

Participated · Seed · Feb 2026

Baba is a patient advocacy platform focused on Medicare and Medicare Advantage beneficiaries, pairing each user with a dedicated human advocate—typically a nurse or social worker—who handles insurance issues, scheduling, paperwork, and care coordination. Complementing this personal support, the company offers a phone- and text-based AI companion that delivers daily engagement, reminders, and early warnings when barriers to care emerge, enabling faster advocate intervention. Baba partners with nursing homes, home care agencies, and home health organizations nationwide to introduce its service during care transitions. Since launch, the platform has helped more than 6,000 families navigate complex healthcare journeys. The company is currently enrolling in an IRB-approved clinical study with Johns Hopkins to evaluate clinical and claims outcomes of its model. Proceeds from its recent seed financing will fund expansion of its Medicare-covered services, deepen provider and health-system partnerships, and further embed advocacy throughout the care continuum. Financially, Baba has secured over $6.5 million in seed capital to accelerate these initiatives.

Led · Seed · Nov 2025

Arbiter is building an AI-driven “operating spine” that pulls patient information from disparate electronic medical records, assesses risk, and triggers automated actions like scheduling, referrals, and post-visit follow-ups. The technology originated from a recently acquired data platform from SecondWave Delivery Systems, giving Arbiter an immediate customer base and multi-year contracted revenue. Today the software is already live with more than 1,000 clinicians and several health plans, despite the company being only about six months old. Beyond the current patient-engagement use case, Arbiter plans to add capabilities that handle prior authorizations, home-based care support, and predictive modeling to forecast disease onset or hospital stays. Founder and CEO Michelle Carnahan, formerly president of Thirty Madison and a 26-year Eli Lilly veteran, has assembled a board and advisory roster that includes VillageMD co-founder Dr. Clive Fields and former Kaiser Permanente CMIO Dr. Ainsley MacLean. Future growth may be accelerated through additional acquisitions targeting data-rich healthcare tools that Arbiter can make more AI-forward. The company’s seed financing provides runway for product expansion and the planned 2024 launch of its unified operating spine with a major national payer-provider network.